Benralizumab in Severe and Refractory PDGFRA-Negative Hypereosinophilic Syndrome

MeSH terms

• Aged
• Antibodies, Monoclonal, Humanized / administration & dosage
• Antibodies, Monoclonal, Humanized / adverse effects
• Antibodies, Monoclonal, Humanized / therapeutic use*
• Biomarkers
• DNA Mutational Analysis
• Disease Management
• Genetic Predisposition to Disease*
• Humans
• Hypereosinophilic Syndrome / diagnosis
• Hypereosinophilic Syndrome / drug therapy*
• Hypereosinophilic Syndrome / etiology*
• Male
• Receptor, Platelet-Derived Growth Factor alpha / deficiency*
• Severity of Illness Index
• Skin / pathology
• Symptom Assessment
• Tomography, X-Ray Computed